<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pharmateca</journal-id><journal-title-group><journal-title xml:lang="en">Pharmateca</journal-title><trans-title-group xml:lang="ru"><trans-title>Фарматека</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2073-4034</issn><issn publication-format="electronic">2414-9128</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">278203</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Mechanisms of antibiotics influence on intestine, role of Enterol in the prophylaxis and treatment of antibiotic-associated diarrhea in children</article-title><trans-title-group xml:lang="ru"><trans-title>МЕХАНИЗМЫ ВОЗДЕЙСТВИЯ АНТИБИОТИКОВ НА КИШЕЧНИК, РОЛЬ ЭНТЕРОЛА В ПРОФИЛАКТИКЕ И ЛЕЧЕНИИ АНТИБИОТИК-АССОЦИИРОВАННОЙ ДИАРЕИ У ДЕТЕЙ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kornienko</surname><given-names>E A</given-names></name><name xml:lang="ru"><surname>Корниенко</surname><given-names>Е А</given-names></name></name-alternatives><bio xml:lang="ru"><p>Санкт-Петербургская государственная педиатрическая медицинская академия, Санкт-Петербург</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Kornienko</surname><given-names>E</given-names></name><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Санкт-Петербургская государственная педиатрическая медицинская академия, Санкт-Петербург</institution></aff></aff-alternatives><aff id="aff2"><institution></institution></aff><pub-date date-type="pub" iso-8601-date="2010-01-20" publication-format="electronic"><day>20</day><month>01</month><year>2010</year></pub-date><volume>17</volume><issue>2</issue><issue-title xml:lang="en">NO2 (2010)</issue-title><issue-title xml:lang="ru">№2 (2010)</issue-title><fpage>33</fpage><lpage>37</lpage><history><date date-type="received" iso-8601-date="2023-02-23"><day>23</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2010, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2010, ООО «Бионика Медиа»</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/2073-4034/article/view/278203">https://journals.eco-vector.com/2073-4034/article/view/278203</self-uri><abstract xml:lang="en"><p>Mechanisms of antibiotics influence on intestine, role of Enterol in the prophylaxis and treatment of antibiotic-associated diarrhea in children</p></abstract><trans-abstract xml:lang="ru"><p>Обсуждается проблема возникновения, диагностики и лечения антибиотико-ассоциированной диареи (ААД). Дана характеристика основных клинических форм ААД и принципы ее диагностики у детей. В случае появления диареи на фоне курса антибиотикотерапии, если возможно, необходимо отменить применяемый антибиотик. При любой из клинических форм ААД показано назначение пробиотиков, в случае необходимости продолжения антибиотикотерапии по поводу основной патологии производят смену антибиотика на менее опасный. Среди известных пробиотиков только два доказали свою эффективность в лечении ААД: Saccharomyces boulardii (Энтерол) и Lactobacillus rhamnosus GG (LGG). Однако сравнительные данные по изучению результатов лечения ААД этими пробиотиками показали, что S. boulardii превосходят LGG по эффективности</p></trans-abstract><kwd-group xml:lang="en"><kwd>Clostridium difficile</kwd><kwd>Saccharomyces boulardii</kwd><kwd>Clostridium difficile</kwd><kwd>Saccharomyces boulardii</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>антибиотики</kwd><kwd>диспепсические расстройства</kwd><kwd>антибиотико-ассоциированная диарея</kwd><kwd>антибиотики</kwd><kwd>диспепсические расстройства</kwd><kwd>антибиотико-ассоциированная диарея</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis 1992;15:573-81.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Beaugerie L, Flahault A, Barbut F, et al. Antibiotic-associated diarrhea and Clostridium difficile in the community. Aliment Pharmacol Ther 2003;17:905-12.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Bouhnik Y, Rambaut JC, Buts JP, ets. Microflora and diarrhoea: antibiotic-associated diarrhoea. Gut Microflora. 2006;181-197.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Wistrom J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2,462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 2001;47:43-50.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>McFarland LV, Brandmarker SA, Guandalini S. Pediatric Clostridium difficile: a phantom menace or clinical reality? J Pediatr Gasroenterol Nutr 2000;31:220-31.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Delmee M, Verellen G, Avesani V, et al. Clostridium difficile in neonates: serogrouping and epidemiology. Eur J Pediatr 1988;147:36-40.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Larson HE, Barclay FE, Honour P, et al. Epidemiology of Clostridium difficile in infants. J Infect Dis 1982;146:727-33.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Ferroni A, Merckx J, Ancelle T, et al. Nosocomial outbreak of Clostridium difficile diarrhea in a pediatric service. Eur J Clin Microbiol nfect Dis 1997;16:928-33.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Rambaud JC, LaMont JT, Buts JP. The clinical significance of Clostridium difficile infections in infants and children. 1996;29-36.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Benoit R, Danquechin DE, Loulergue J, et al. Diarroea post-antibiotique : role de Klebsiella oxytoca. Gasroenterol Clin Biol 1992;16:860-64.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Rambaud JC, LaMont JT, Lamont JT. Recent advances in the structures and function of Clostridium difficile toxins. 1996;72-86.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Price AB. Pseudomembranous colitis. 2005;15-172.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile-associatied diarrhea: a review. Arch Intern Med 2000;161(525):5-33.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Rambaud JC, Ducluzeau R, Cooperstock M. Clostridium difficile in infants and children. 1990;81-94.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Harris PR, Figueroa-Colon R. Rectal prolapse in children associated with Clostridium difficile infection. Pediatr Infect Dis J 1995;14:78-80.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Garlani MJ, Murray JC, Morad AB, et al. Chronic osteomyelitis caused by Clostridium difficile in an adolescent with sickle cell disease. Pediatr Infect Dis J 1996;15:1054-56.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Thomas DFM, Fernie DS, Bayston R, et al. Clostridial toxins in neonatal necrotising enterocolitis. Arch Dis Child 1984;59:270-83.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Cetina-Sauri G, Sierra Basto G. Therapeutic evaluation of Saccharomyces boulardii in children with acute diarrhea. Annales de Pediatrie 1994;41(6):397-400.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Castaneda C, Garcia E, Santa Cruz M, et al. Effects of Saccharomyces boulardii in children with chronic diarrhea, especially cases due to giardiasis. Revista Mexicana de Puericultura y Pediatria 1995;2:12.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Castagliuolo I, LaMont JT, Nikulasson ST, et al. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infection and Immunity 1996;12:5225-32.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Gedek BR. Adherence of E.coli serogroup O-157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 1999;42(4):261-64.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Cherucka D, Dahan S, Mograbi B, et al. Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infection and Immunity 2000;68:5998-6004.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Dahan S, Dalmasso G, Imbert V, et al. Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infection and Immunity 2003;72(2):766-73.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Buts JP, Bernasconi P, Van Craymest MP, et al. Response of human and rat small intestinal mucosa to oraladministration of Saccharomyces boulardii. Pediatric Research 1986;20:192-96.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Sougiolzis S. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kB-mediated IL-8 gene expression. Biochem Biophys Res Commun 2006;2:23.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Girard-Pipau F, Pompei A, Schneider S, et al. Intestinal microflora, short chain and cellular fatty acids, influence of a probiotic Saccharomyces boulardii. Microb Ecolog in Health Dis 2002;14:220-27.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Buts JP, Corthier G, Delmee M. Saccharomyces boulardii for Clostridium difficile- associated entheropathies in infants. J Pediatr Gastroenterol Nutr 1993;16:419-25.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Costalos C, Skouteri V, Gounaris A, et al. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev 2003;11:89-96.</mixed-citation></ref></ref-list></back></article>
